
Udenafil
CAS No. 268203-93-6
Udenafil( DA-8159 )
Catalog No. M13819 CAS No. 268203-93-6
A potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 65 | Get Quote |
![]() ![]() |
10MG | 110 | Get Quote |
![]() ![]() |
25MG | 215 | Get Quote |
![]() ![]() |
50MG | 345 | Get Quote |
![]() ![]() |
100MG | 503 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameUdenafil
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.
-
DescriptionA potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.Sexual Dysfunction Approved(In Vitro):Udenafil is an oral PDE5 inhibitor. Udenafil significantly increases cAMP and cGMP levels and are more highly distributed in the prostate than plasma.
-
In VitroUdenafil is an oral PDE5 inhibitor. Udenafil significantly increases cAMP and cGMP levels and are more highly distributed in the prostate than plasma.
-
In Vivo——
-
SynonymsDA-8159
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaEndocrinology
-
IndicationSexual Dysfunction
Chemical Information
-
CAS Number268203-93-6
-
Formula Weight516.6561
-
Molecular FormulaC25H36N6O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 33 mg/mL
-
SMILESO=S(C1=CC=C(OCCC)C(C(NC2=C3N(C)N=C2CCC)=NC3=O)=C1)(NCCC4N(C)CCC4)=O
-
Chemical NameBenzenesulfonamide, 3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-4-propoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Salem EA, et al. Curr Opin Investig Drugs. 2006 Jul;7(7):661-9.
2. Lee CH, et al. J Sex Med. 2010 Jul;7(7):2564-71.
3. Kang HE, et al. Br J Pharmacol. 2009 Mar;156(6):1009-18.
molnova catalog



related products
-
AWD 12-281
AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).
-
Cilostazol
Cilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo.
-
TAK-915
TAK-915 (TAK915) is a highly potent, selective, brain-penetrating and orally active phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 0.61 nM.